J&J's Erleada Approved By FDA In New Prostate Cancer Indication

 
• By Jessica Merrill
  
Prostate-cancer
Erleada was approved by FDA for metastatic castration-sensitive prostate cancer

More from Anticancer

More from Therapy Areas